Cathie's Ark Logo
Adaptive Biotechnologies Corp Logo

ARKG Holdings of Adaptive Biotechnologies (ADPT) - Updated Daily

Liquid Biopsy
Date
Direction
Shares
Fund Weight
Fund
June 2, 2023
BUY79.853k0.0277%ARKG
June 1, 2023
BUY81.438k0.0279%ARKG
May 30, 2023
BUY109.277k0.0373%ARKG
May 26, 2023
BUY33.099k0.0111%ARKG
May 25, 2023
BUY304.237k0.1001%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
3.49%$1.01b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
8🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
33$26.40
🎫ARK Ownership Percent
7.09%
Description
we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee’s contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and
Website
adaptivebiotech.com

Other ETFs That Hold ADPT

Ticker
NameWeight
ARKGARK Genomic Revolution ETF4.07%
IBBiShares Biotechnology ETF0.11%

Research Notes and Commentary for ADPT

No Research Notes Found for ADPT